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Alkaline phosphatase is an enzyme that has been bio-
chemically characterized and associated with viral and 
chemical induced thymic lymphomas. Though its physiological 
role is yet unknown, it is believed to be connected with 
active transport. This hypothesis is supported by histo-
chemical localization of APase by electron microscopy to 
absorptive surfaces, such as convoluted tubules of the 
kidneys, small intestinal mucosa, syntrophoblast of the 
placenta, and the cell surface of I• .22!i,. Various cyto-
chemical studies have led to conflicting thoughts on the 
development of thymic lymphomas and the appearance of Apase 
activity~ Siegler and Rich (1967) using the Burstone and 
Gomori cytochemical techniques observed that thymic APase 
was elevated only after the lymphoma had proliferated to 
the extent that this organ was at least three-fold its nor-
" mal weight. Lagerlof and Kaplan (1967) undertook studies to 
confirm the observations of previous investigators that Apase 
activity appeared during the development of thymic lymphomas. 
Employing the use of a more sensitive technique, histological 
and histochemical studies on radiation induced mouse lym-
phomas revealed that the development of APase activity in 
murine thymic lymphomas was directly related to the develop-
ment of neoplastically transformed cells in the thymus. 
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Wilson et al. (1972) studying acid and alkaline phosphatase 
in murine leukemia using the techniques of Siegler and Rich 
(1967) also suggested that APase elevation is a secondary 
event occurring only after the onset of murine lympho-
blastic leukemia. Exactly how APase is produced in the 
cell is another unknown fact. The enzyme is not normally 
present in the C57Bl mouse thymus after 16 days gestation, 
however it is present in the case of thymic lymphomas. Lumb 
and Doell (1970) in their biochemical analysis of APase in 
viral and chemical induced thymic lymphomas found that ac-
cording to pH optimum, heat inactivation, and substrate 
specificity experiments the APase activity in mouse lymphoma 
cells resembled the activity found in normal mouse spleen. 
These findings seemed to indicate that the cell itself may be 
responsible for the product.ion of APase thus rendering it an 
abnormal activation of a normal embryonic function. 
Fishman et al. (1968) studying serum phosphatase iso-
enzymes in cancer patients discovered a male patient with a 
bronchogenic carcinoma, whose serum contained an APase indis-
tinguishable from the APase found normally in the placenta 
and serum of pregnant women. It has since been found in a 
large number of human tumors and has been given the name 
Regan isoenzyme after the patient in whom it was first found. 
The four tissues used in the present comparative substrate 
specificity study were C57Bl mice lymphoma, spleen, 16-day-
embryo and placenta to serve as a comparison between normal 
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and leukemic tissues. The biochemical parameters used were 
pH optimum, heat inactivation and substrate ratios with the 
substrates p-nitrophenyl phosphate (PNPP), beta-glycero-
phosphate (GlyP) and pyrophosphate (PP). 
CHAPTER II 
REVIEW OF LITERA'l'URE 
Role of APase in Mouse Leukemia 
The enzyme Alkaline Phosphatase had been found in a 
variety of tissues from many different sources. Its true role 
is unknown, but it is believed to be connected to active trans-
port because of its histochemical localization by electron 
microscopy to absorptive surfaces • .. 
Lagerlof and Kaplan (1967) undertook studies to confirm 
the observation that Apase activity appeared during the 
development of thymic lymphomas. Their histochemical, 
histological, radiation induced, viral induced and chemical 
treated mice studies revealed that the development of APase 
activity in murine thymic lymphomas is directly related to 
the development of thymic lymphoid neoplastically transformed 
cells. 
Siegler and Rich (1967) using techniques other than those 
" employed by Lagerlof and Kaplan observed that thymic APase was 
elevated only after the lymphoma had proliferated to the extent 
that this organ was at least threefold its normal weight. 
Wilson et al. (1972) studying acid and alkaline phospha-
tase in Murine leukemia and using the Burstone and Gomori 
cytochemical techniques like Siegler and Rich (1967) found 
that alkaline phosphatase elevation is a secondary event 
occurring after the onset of murine lymphoblastic leukemia. 
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Cory et al. (1971) in a comparative study of the 
enzymic properties of alkaline phosphatase in liver ex-
tracts from normal and leukemic mice observed a marked in-
crease in APase activity of viral infected over the normal 
mouse. 
Structure and Mechanism of!• s2!! APase 
Garen and !-Levinthal (1960) purified alkaline phos-
phatase of Escherichia~ in their work of fine structure 
genetic analysis and reported several physical and chemical 
properties of the enzyme. Their work revealed that the 
amount of!~~ alkaline phosphatase is optimal when the 
cells are starved for phosphate; they found all activity 
located in a single electrophoretic band~ The pH optimwn is 
at pH 8 and no detectable activity occurs below pH 6. Crude 
extracts could be maintained at 85 degrees for 30 minutes 
without losing activity. while in the purified state the 
enzyme is unstable at the same temperature. Certain phos-
phomonoesters such as PNPP and beta-glycerophosphate liberate 
activity from the enzyme, while ATP and pyrophosphate did not 
liberate any activity~ 
Heppel et a1.· (1962) using purified !~ .22!! alkaline 
phosphatase received from Garen and Levinthal (1960) in a 
substrate specificity study of!• £2!! found that ATP, sodiwn 
pyrophosphate, PNPP, and beta-glycerophosphate were indeed 
hydrolyzed by!• coli alkaline phosphatase. 
Fernley and Walker (1969) in their studies of I• £21:! 
----------- -------------------------
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APase during the steady state phases noticed that the pH pro-
files for phosphorylation and dephosphorylation are different 
and postulated that the ionizing group which determines con-
formation during one is not involved in the other. 
Morris and Schlesinger (1972) studying pro1ine analogues 
effects on!~ coli APase found that 3,4,-dehydroproline was 
able to substitute for praline in protein synthesis in APase 
and led to the formation of an active enzyme. In this same 
study they found that by substituting azetidine-2-carboxylate 
for praline, active enzyme formation was prevented but mono-
meric forms of APase were produced. 
Studies on Mammalian APase Relating to its Function 
Placenta APase was first purified by Ahmed and King 
( 1960) who used several methods and found the butanol 
extraction procedure to produce the highest percentage of 
purity and the highest specific activity, probably because 
of its ability to disrupt the lipoprotein without denaturing 
"' the enzyme. 
Sadovsk.y and Zuckerman (1965) experimenting with two 
substrates PNPP and beta-glycerophosphate found an APase 
specific to normal pregnancy. 'l'heir experiments employed 
the use of non-pregnant healthy women, women suffering from 
liver and bone diseases, newborn infants and women at 
delivery~ The activity of women at delivery and placenta 
were significantly higher than the others tested. 
McMaster et al. (1964) in a study to determine the pre-
sence or absence of heat stable APase in serum found that 
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the increase in serum APase in late pregnancy is due to an 
increase in heat stable enzyme, and that the heat stable APase 
found in maternal circulation is of placental origin. 
Kitchener et al. (1965) studying APase in maternal and 
fetal sera at various stages of pregnancy found that serum 
APase rises significantly during the latter half of pregnancy 
reaching its peak at term and declining during the weeks 
following delivery~ 
Birkett et al~ (1966) in an immunological study of 
serum APase in pregnancy found that APase in maternal sera at 
term is partially inactivated by an anti-human tissue pla-
cental APase antibody~ This inactivation is not observable 
in sera from non-pregnant or newborns, therefore further 
implicating that the rise in serum APase during pregnancy is 
due to the circulation of the placental enzyme. 
Fernley and Bisaz (1968) studying phosphorylation of calf 
intestinal APase noticed that as the pH is raised there is a 
rapid increase in steady state rate while increase of phos-
phorylation in pre-steady state remains unchanged. 
Fishman et al. (1968) discovered a placental-like APase 
in a male patient named Regan with a bronchogenic carcinoma. 
The isozyme in the serum of the patient was similar to human 
placental isozyme in several properties, such as high sensi-
tivity to the inhibitor L-phenylalanine, heat stability and 
they contain similar electrophoretic patterns on starch gels. 
Lumb and Doell (1970) in their biochemical studies of 
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APase in viral and chemical induced thymic lymphoma found 
that in their pH optimum. heat inactivation and substrate 
specificity experiments the APase activity in mouse lymphoma 
cells resembles the activity found in the normal mouse spleen. 
Nathanson and Fishman (1971) in their effort to establish 
an incidence of Regan isoenzyme in relation to site of tumor 
and fluctuations in relation to course of disease discovered 
that approximately 14% of cancer patients have detectable 
Regan isoenzyme with the highest percentage occurring in 
patients with carcinomas of the ovary. pancreas, stomach, 
lung and breast. 
Nakayama et al. (1970) demonstrated the existence of a 
heat stable APase in a patient with pleuritis carcinoma dif-
ferent from that of the placenta APase or Regan isoenzyme. 
The three APases shared identical heat stability. electro-
phoretic mobility and immunological property. but the 
pleuritis APase was different in terms of sensitivity to 
L-leucine. ED'l'A and enzyme kinetics. They called this 
isoenzyme Nagao isoenzyme, the name of the patient in whom it 
was found. 
Leroux and Perry (1971) studying placental characteristics 
of a variety of mammals found that placental heat stability 
patterns fall into three categories, heat stable. heat 
labile and an intermediate group~ Of the animals studied. 
rat. mouse. rabbit. dog. and reindeer placental APase is heat 
labile~ Like humans. llamas, alpacas. cows and zebras 
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placental APase is heat stable. Saiga and pig placental 
APase fall into the intermediate group. 
Beratis et al. (1971) studying the placental APase found 
like others that there are two principal components of the 
APase when separated by starch gel electrophoresis, a fast-
moving component (Component I), and a slow-moving component 
(Component II). They discovered that storage of Component 
II resulted in conversion of it to Component I and that this 
conversion rate increased with an increase in temperature. 
Control of Formation of APase 
Cox and Macleod (1961) studying hormonal induction of 
APase in a human epithelial cell culture line found that a 
hydrocortisone analogue, prednisolone can induce APase 
activity and that this induction unlike bacteria !• coli is 
independent of ion concentration. 
Nitowsk.y and Herz (1963) in their experiments on 
hormonal regulation of APase in dispersed cell cultures 
observed two types of responses, one where with certain cell 
lines growth with prednisolone resulted in an increase of 
2-8 times that of the control cultures and with other cell 
lines, either no increase or a decrease in activity was 
observed. 
Cox et al~ (1967) studying alkaline inorganic pyrophos-
phatase activity in mannnalian cells APase found that both of 
the activities involves a single protein. They were able to 
demonstrate this by purification of APase and alkaline 
10 
pyrophosphatase concomitantly, precipitation, electrophoresis, 
subcellular localization and hormonal and substrate induction. 
Elson and Cox (1969) found that APase produced by HeLa 
cells is similar to that of the fetal forms of the enzyme 
found in the placenta. They have similar molecular weights, 
immunological properties and electrophoretic patterns, except 
the HeLa cells APase is slower moving. 
Nose et al~ (1973) studying APase in cultured cells 
observed two distinctly different activities of APase in crude 
extracts of various cell strains~ APase I was highest around 
pH 10~0 and was inhibited by cyanide or beta-mercaptoethanol 
and APase II was shown to be optimal around pH 8. 6 and was 
inhibited by p-chloromercuribenzoate. 
CHAPTER III 
MATERIALS AND METHODS 
Source of Tissue 
Tissues used in this research were C57Bl mice 16-day 
placenta, 16-day embryo, normal male spleen and lymphomas. 
The 16-day embryos were obtained by anesthesizing 16-day 
pregnant females, dislocating the cervical vertebra and 
surgically removing the placentas and embryos, placing 
them on ice or in vials to be frozen. The spleens were 
obtained from normal males. They were then treated in the 
manner described above. Lymphomas were obtained by in-
jecting C57Bl mice with cell free extract (CFE) through 
successive viral passage, transferring of cells from lym-
phoma (H-254) and chemical injection of one-day mice with 
6-mercaptopurine (H-121) that followed with weekly injections 
for four successive weeks. 
Substrates 
Para-nitrophenyl phosphate (PNPP) in a concentration of 
33.3 mM, tetra-sodium pyrophosphate (PP) in a concentration 
of 50 mM, and beta-glycerophosphate (GlyP) in a concentration 
of 50 mM were used as substrates. 
Buffer 
Ammediol buffer (2-amino-2-methyl-1,3 propandiol) in a 
final concentration of o.os M with 5 mM MgC12 was adjusted to 
-the appropriate pH. 
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Crude Extract Preparation 
Tissues were ground in a glass homogenizer attached to 
a Tri-R-Tube with an electric motor in 0.015 M NaCl solution. 
The tissues were first minced into fine pieces with scissors, 
the minced material was placed into the grinder and the 
volume was brought up to a maximum of 7 ml with 0.01s M 
NaCl and ground well. The solution was next filtered 
through gauze three or four layers thick. The extract was 
then placed into serum vials and heat inactivation or pH 
optimum assays performed or the extract was frozen for later 
biochemical use. 
PNPP Assay 
A water bath was preheated to 37 c and tubes were pre-
pared according to the method of Lumb and Doell (1970), by 
adding o.a ml of ammediol buffer pH 10. To each of these 
tubes was added 0.1 ml extract (placenta, embryo, spleen or 
lymphoma). The tubes were then allowed to incubate at 37 c 
for five minutes bringing them to equilibrium. PNPP was then 
added in the amount of 0.1 ml to each of the tubes at 30 
second intervals. The tubes were then allowed to incubate 
at 37 C for exactly 30 minutes, 2 ml of EDTA/NaOH (O. 1 M 
EDTA and O. 5 N Na OH) was then added to each tube to end the 
reaction. Blanks were prepared in the same manner except 
that EDTA/NaOH was added to the tubes prior to the addition 
of PNPP. The absorbance was then read on a Turner 330 




Phosphate assays were performed using the methods of 
Lecocq and Inesi (1966). A water bath was preheated to 
37 C and tubes were prepared in the manner described in the 
PNPP assay. At the end of the 30 minute incubation period 
2 ml of Vandate Reagent III (Lecocq and Inesi, 1966) was 
added to each tube. Blanks were prepared in four ways, 
' (1) Buffer (0.8 ml) and 0.1 ml substrate were incubated 
30 minutes at 37C. Then 2 ml Reagent III was added, followed 
by 0.1 ml extract. 
(2) Buffer (0.8 ml) and 0.1 ml extract were incubated 
30 minutes at 37 c. Then 2 ml Reagent III was added, 
followed by 0.1 ml substrate. 
(3) The substrate blank contained o.e ml buffer, 0.1 ml 
substrate, 0.1 ml deionized water and 2 ml Reagent III. 
(4) The extract blank contained o.e ml buffer, 0.1 ml 
extract, 0.1 ml deionized water, and 2 ml Reagent III. 
Generally, blank (1) was used to subtract nonenzymatically 
produced phosphate. The others were run to be certain of all 
the reagents. All tubes were centrifuged at 5000 rpm on the 
IEC at 4 c. The absorbance was read in a quartz cuvette on 
a Turner 350 spectrophotometer using the Turner UV attachment 
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with a Chem-puter-3 digital readout (Mediconics International). 
Phosphate concentration was determined by referring to a 
standard curve. 
pH Optimum 
Several pH's of Ammediol buffer were prepared, ranging 
from pH 7 to pH 11. Potassium fluoride was added to the 
buffer to inhibit residual acid phosphatase activity when PP 
" was used as a substrate (Hubscher and West, 1965). A water 
bath was preheated to 37 C and the experiment was performed 
in the manner described in the phosphate assay. 
Heat Inactivation 
Two water baths were pre-heated; one to 55 C for 
inactivation of the enzyme and one to 37 C for PNPP assay. 
Tubes were prepared in the manner described in the PNPP 
assay. Four tubes were used for each time interval of 
o, 4, 8, 12 and 16 minutes. The O tubes were placed in an 
ice bucket, the remainder were placed in the 55 C water bath, 
after 4 minutes the tubes labeled 4 minutes were taken out 
and placed on ice, after 8 minutes the tubes labeled 8 
minutes were taken out and placed on ice and so on until the 
tubes labeled 16 minutes were taken out and placed on ice. 
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The tubes were then allowed to equilibrate to 37 C for five 
minutes and assayed with the appropriate substrate. The heat 
inactivation rate is described in the equation 
A=A~~ 
0 
where A0 is the unheated activity. A is the activity remaining 
after time t and k is the heat inactivation rate. The rate 
was determined by Least Squares analysis of the data expressed 
as the natural log of activity versus time at 55 c. 
CHAPTER IV 
EXPERIMENTAL RESULTS 
Table I shows the optimum pH of all tissue extracts 
(lymphoma. spleen. placenta and embryo) using GlyP and PP as 
substrates. It was found that the optimum pH of placenta and 
embryo extracts was pH 9.a. while the optimum pH of spleen 
and lymphoma extracts was pH 10.0 when GlyP was used as the 
substrate. The optimum pH. using the substrate PP, of pla-
centa and embryo extracts was pH 9.0, spleen extract, pH a.a, 
and lymphoma extract pH a.s. 
Figures 1-4 illustrate the heat inactivation of lymphoma, 
spleen, placenta and embryo extracts using three substrates 
PNPP, GlyP and PP. The rates of inactivation of PNPPase and 
GlyPase appear similar in each tissue extract, while the rate 
of inactivation of PPase activity appears greater in each 
extract than that of PNPPase and GlyPase activity. 
Figures 5-7 show a comparison of the heat inactivation 
pattern of the four tissue extracts with each of the three 
substrates. For a statistical comparison of the heat inacti-
vation rates, slopes of the lines in Figures 1-7 were cal-
culated. These heat inactivation rates were averaged for at 
least three experiments. the means and standard deviations 
of which are summarized in Table . 2 ~ The significance of 
these values were determined by the student's t-test. The 




Optimum pH of Alkaline Phosphatase Activities 
Optimum pH 
GlYP pp 
Lymphoma 10.0 a.s 
Spleen 10.0 a.a 
Placenta 9.8 9.0 
Embryo 9.B 9.0 
Fig. 1. Heat inactivation of lymphoma phosphatase 
activities. The substrates used were p-nitro-
phenyl phosphate (PNPP) at a concentration of 
33.3 mM at pH 10.0, beta-glycerophosphate (GlyP) 
at a concentration of SO mM at pH 10.0 and 
pyrophosphate (PP) at a concentration of SO mM 
at pH S.S. 
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Fig. 2. Heat inactivation of spleen phosphatase activities. 
The substrates used were p-nitrophenyl phosphate 
(PNPP) at a concentration of 33.3 mM at pH 10.0, 
beta-glycerophosphate (GlyP) at a concentration of 
50 mM at pH 10.0 and pyrophosphate (PP) at a 
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Fig. 3~ Heat inactivation of placenta phosphatase 
activities~ The substrates used were p-nitrophenyl 
phosphate (PNPP) at a concentration of 33.3 mM at 
pH 10.0, beta-glycerophosphate (GlyP) at a con-
centration of 50 mM at pH 9.8 and pyrophosphate 
(PP) at a concentration of 50 mM at pH 9.0. 
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Fig. 4. Heat inactivation of embryo phosphatase activities. 
The substrates used were p-nitrophenyl phosphate 
(PNPP) at a concentration of 33.3 mM at pH 10.0, 
beta-glycerophosphate (GlyP) at a concentration of 
50 mM at pH 9.8 and pyrophosphate (PP) at a con-
centration of 50 mM at pH 9.0. 
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Fig. s. Heat inactivation of p-nitrophenyl phosphatase 
activities. Lymphoma, spleen, placenta and 
embryo phosphatase acting upon the substrate 
p-nitrophenyl phosphate. 
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Fig. 6. Heat inactivation of beta-glycerophosphatase 
activities. Lymphoma, spleen, placenta and 
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Fig. 7. Heat inactivation of pyrophosphatase activities. 
Lymphoma, spleen, placenta and embryo phosphatase 
acting upon the substrate pyrophosphate. 
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confidence level and 5.84 for the 99% confidence level. 
Table 3 shows a comparison of the heat inactivation rates of 
the three phosphatase activities between the tissues. The 
only significant difference between tissues was that of the 
PNPPase activity of the embryo and the spleen extracts. This 
difference was found at the 95% confidence level, but not at 
the 99% confidence level (Goldstein, 1964). Table 4 shows a 
comparison of the heat inactivation rates of the three phos-
phatase activities on the four tissues. Generally the PPase 
activity was significantly different. In the lymphoma 
extract a significant difference was found between PPase and 
PNPPase. A significant difference was also found between 
PPase and PNPPase in the spleen extract. There were no 
significant differences between substrates in the placenta 
extract. The only tissues extract exhibiting a significant 
difference between GlyP and PPase was the embryo extract. 
This difference occurred at the 99% confidence level. 
Table 5 indicates the specific activities of each tissue 
extract and the ratios of GlyP and PP to PNPP. Placenta 
extract had a very high specific activity compared to spleen 
extract which had a low specific activity, approximately 0.4. 
It was also found that the distribution of PPase in the spleen 
extract was high while the distribution of the nonspecific 
APase was low. 
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TABLE 2 






0.13 ± o.o4 
0.11 ± 0.01 
0.13 ± 0.03 
0.1s + o.o3 
Heat Inactivation Ratea 
GlyP 
0.16 ± 0.14 
0.14 ± o.oe 
0.10 ± 0.02 
o.o9 ± o.o4 
pp 
0.33 ± 0.12 
o.31 ± 0.06 
0.23 ± 0.12 





a The mean and standard deviation are given for at least 
three experiments. 




A Statistical Comparison of Heat Inactivation Rates 
of Phosphatases of Different Tissues 
Tissues Compared PPase GlyPase PNPPase 
Placenta vs Embryo -1.24 * o.s6 -1.36 
Placenta vs Spleen -0.78 -0.82 -2.04 
Placenta VS Lymphoma -1.685 -0.78 -1.52 
Embryo vs Spleen 0.38 -1.05 3.265 
Embryo vs Lymphoma o.75 -0.94 3.057 
Spleen vs Lymphoma -0.845 0.21 -1.04 
* t-value as calculated by the students• t-test at the 
99% confidence level. 
28 
TABLE 4 
A Statistical Comparison of Heat Inactivation Rates 
of Phosphatase Activities Toward Different Substrates 
Phosphatase 
Activities Compared Lymphoma Spleen Placenta 
* PNPPase VS GlyPase 0.191 1.225 1.280 
GlyPase vs PPase 2.058 2;199 1.830 
PPase vs PNPPase 1.120 4.280 2.050 
* t-value as calculated by the students• t-test at the 







$ubstrate Ratios of Alkaline Phosphatase Activities 
Tissue Specific Activity * GlyP/PNPP PP/P~ 
Lymphoma 2.20 1.35 o.74 
Spleen 0.39 1.32 2.25 
Placenta 4.12 0.84 0.40 
Embryo 1.81 1.os 0.74 
* Specific Activity= moles p-nitrophenol released in 30 
minutes at 37 C per mg protein. 
CHAPTER V 
DISCUSSION AND CONCLUSIONS 
The association of APase activity with the cell membrane 
of thymic lymphoma cells has been demonstrated by many in-
vestigators (Smith, 1962; Metcalf et al., 1962; Cox and 
" Griffi:n, 1965; Lagerlof and Kaplan, 1967; Siegler and Rich, 
1967; Lumb and Doell, 1970; Wilson et al., 1972). These 
studies have been histological, histochemical and biochemical 
in nature and have revealed many facts about the enzyme APase. 
In the present experiments the optimum conditions for 
GlyP and PP activities were determined for C57Bl mice 
placenta, embryo, spleen and lymphoma extracts. With GlyP 
as the substrate the optimwn pH for placenta and embryo 
extracts was pH 9.8 and the optimum pH for spleen and lym-
phoma extracts was pH 10. o. This is consistent with the data 
presented by Lumb and Doell (1970) where all tissue extracts 
had a pH optimum of pH 10.0 using the substrate PNPP. When 
PP was used as the substrate the optimum pH of placenta and 
embryo extracts was pH 9.0, while the optimum pH for spleen 
30 
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extract was a.a and for the lymphoma extract the optimum pH 
was e.s. 
Heat inactivation analysis show the rate of inactivation 
of all extracts are similar when PNPP or GlyP were used as 
substrates. These data are consistent with those of Neuman 
et al, (1971) who showed that approximately 50% of all the 
activity in the same strain was lost after 5 minutes, using 
the substrate PNPP. when treated in the same manner. On the 
other hand when PP was used as the substrate the pyrophos-
phatase (PPase) activity was found to be completely in-
activated after 8 minutes of exposure to the preincubation 
temperature of 55 c. Since heat inactivation is definitely 
an effect of the enzyme itself, this provides evidence that 
the PPase activity is a different enzyme. Substrate ratios 
show no significant difference between any of the tissues 
with GlyP or PP as substrates, except in the case of the 
spleen, where the PPase activity is nearly twice as high. 
These findings seem to indicate that there are two distinct 
and different activities occurring with the use of PP and 
PNPP or GlyP as substrates. If the fact of having a different 
pH optimum was the only one existing in the parameters used 
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it could be concluded that the pH affected the structure of 
the subst_rate itself and therefore accounted for the dif-
ference. This is supported by the work of Floyd (1974) in 
a comparative electrophoretic study of APase in normal and 
leukemic tissues using the substrates PNPP, GlyP, alpha-
naphthol phosphate (a-nap) and PP, where it was found that 
the mobility of the PPase activity was considerably slower 
than the enzyme which hydrolyzed the other substrates. After 
treatment with neuraminidase the mobility of the nonspecific 
activity was slowed in all tissue extracts with the exception 
of embryo extract whose mobility remained unchanged. Spleen 
extract had more PPase activity than the other tissue ex-
tracts, evident from the darker staining of the acrylamide 
gels. Lumb et al. (1974) in an effort to establish the 
levels of activation and inhibition using the three substrates 
PNPP, GlyP and PP in the same four tissu4 extracts found that 
the PPase activity in all four extracts is significantly less 
inhibited by EM'A and to a less extent phenylalanine and the 
inhibition of both PNPPase and GlyPase activity was similar. 
It is therefore concluded that there are two enzymes involved 
in the hydrolysis of the substrates in C57Bl mice tissue, a 
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specific PPase and a nonspecific APase. 
This conclusion is in contrast to that of several in-
vestigators who have provided evidence to show that certain 
mammalian APases also possess PPase activity (Fernley and 
Walker, 1966; Moss et al., 19671 Melani and Farnaratto, 
1969; and Miles and Nayudu, 1971). Cox et al. (1967) in a 
study of PPase in mammalian cell APase, demonstrated by 
purification of the PPase, that by precipitation, electro-
phoresis, subcellular localization and hormonal and substrate 
induction the two activities involved a single enzyme. Heat 
inactivation experiments reported in this thesis do not 
correlate with data given by Sussman and Laga (1968) in which 
PPase showed a rate of inactivation consistent with that of 
PNPPase. Melani and Farnarano (1969) studying rat kidney 
APase and PPase in purified rat kidney cells found by heat 
inactivation and starch gel electrophoresis analysis that 
APase and PPase were manifestations of the same enzyme, 
however he failed to recognize the differences produced by 
zinc inhibition, eysteine inhibition and pH optimum. Moss 
(1969) in working with metal ions using PNPP and PP as 
substrates on human placenta found that APase possessed both 
34 
orthophosphatase and PPase activities taking into account the 
interactions between metal ions and PP. Miles and Nayudu 
(1971) working with SWR/J mouse kidney found the· optimum pH 
with PNPP to be pH 10.2, GlyP pH 9.8 and PP pH 8.9. These 
pH values are consistent with the data provided here. They 
also showed that the heat inactivation rate of PNPPase and 
PPase was slower than GlyPase. To the contrary this is not 
what happens in C57Bl mouse placenta, embryo, spleen and 
lymphoma extracts in which the evidence shows that it was 
found PNPPase and GlyPase to be more heat stable than PPase. 
Herz and Kaplan (1972) in comparing the effect of serum on 
PPase and APase synthesis in H~ S3 and other human cell 
lines demonstrated that in heteroploid cells of human origin 
the specific activity of PPase is not as rigidly controlled 
by the concentration of serwn in the culture medium as APase 
activity, though they did not rule out the possibility that 
APase and PPase activities are due to the same enzyme. They 
did suggest, however, that there was a possibility of one 
enzyme possessing both activities and that maybe serum or 
some of its components modify the enzyme molecule to such an 
extent that it is converted into a less efficient APase 
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without significantly affecting its capacity to hydrolyze 
PPase. Conflicting results have been reported in reference 
to the subcellular localization of APase activity. Griffin 
et al. (1967) and Spencer and Macrae (1972) reported APase 
activity as being localized in the nucleus and Bosman et al. 
(1968) reported APase activity as being localized in the 
membrane. Singer et al. (1974) found by electron microscopic 
histochemical and biochemical subcellular fractionation 
studies that in HeLa cells APase localization is membrane 
bound. Lumb et al. (1974) found the nonspecific APase 
activity is membrane bound, while that of the PPase is nuclear 
bound. 
There is a fraction of APase that is not completely 
inactivated after heat treatment in C57Bl mice with the use 
of PNPP or GlyP as substrates. It is suggested that this 
fraction is a heat stable isoenzyme of APase and could be 
characterized by pH optimum, substrate specificity, inhibition 
and activation and phosphotransferase activity. Floyd (1974) 
demonstrated the presence of two bands in embryo and ll'Jllphoma 
extracts thus providing additional evidence for the existence 
of a heat stable isoenzyme of APase. This additional band 
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and the fraction of presumably heat stable APase can be 
clarified by purification, of which experiments are now in 
progress, so that molecular weight, amino acid composition, 
carbohydrate composition, and metal ion requirements may be 
established. From these results one could conclude that 
perhaps the production of APase in leukemic cells really is 
an abnormal activation of a normal embryonic function such 
as embryonic carcinomas or the Regan isoenzyme of cancer. 
There was no significant difference between tissue extracts 
with any of the substrates used, by pH or heat inactivation 
analysis, even though there was a difference in specific 
activities. Floyd (1974) found that the embryo extract was 
resistant to neuraminidase with all orthophosphates used as 
substrates. Lumb et al. (1974) found that by kinetic 
experiments embryo had a considerably higher Km than the 
other tissue extracts. These differences could be explained 
on the basis of embryo being a collection of APases from 
different tissues and perhaps a better comparison is with the 
embryonic thymus. 
The ultimate objective of this work is to determine the 
mechanism of activation of embryonic functions during 
37 
malignant transformation. The presence of APase activity up 
to 16 days gestation and in adult C57B1 mice thymic lymphoma 
suggest that this malignant transformation is a derepressed 
embryonic function. Since the mechanism of malignant trans-
formation in leUk:emia is still not clear, additional experi-
ments that can provide useful information in elucidating its 
mechanism includes activation of the enzyme APase in vitro 
by chemical carcinogens and the C57 LeUkemia virus and 
studying its mechanism of activation. 
CHAPTER VI 
SUMMARY 
1. A comparative substrate specificity analysis was made of 
C57Bl mice lymphoma, spleen, placenta and embryo APase 
activity by the biochemical parameters of pH optimum, heat 
inactivation and substrate ratio determinations. 
2. The pH optimum was around pH 10.0 for each tissue 
extract when GlyP was used as the substrate, while the pH 
optimum was around pH 9.0 when PP was used as the substrate. 
3. The rates of inactivation of PNPPase and GlyPase in all 
tissue extracts are similar, while the rate of inactivation 
of PPase is greater in all tissue extracts. 
4. The distribution of nonspecific APase is low and the 
specific activity is very high, on the other hand, distri-
bution of PPase is high and the specific activity is very 
low. 
s. The presence of APase activity up to 16 days gestation 
in the embryo thymus and in adult C57Bl mice thymic lymphoma 
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